Market Closed -
Japan Exchange
02:00:00 2024-03-28 am EDT
5-day change
1st Jan Change
14,335
JPY
+0.24%
+0.56%
-11.97%
Sales 2024 *
959B
6.33B
Sales 2025 *
1,042B
6.88B
Capitalization
568B
3.75B
Net income 2024 *
24.82B
164M
Net income 2025 *
26.81B
177M
EV / Sales 2024 *
0.56
x
Net cash position
2024
*
31.37B
207M
Net cash position
2025
*
32.95B
218M
EV / Sales 2025 *
0.51
x P/E ratio 2024 *
22.9
x
P/E ratio 2025 *
21.2
x
Employees
-
Yield 2024 *
0.81%
Yield 2025 *
0.9%
Free-Float
47.53%
Duration
1 day 1 week 1 month 3 months 6 months 1 year 5 years 10 years
Period
5 minutes 15 minutes 30 minutes 1 hour 1 day 1 week 1 month 1 year
Style
CandleStick End-of-day OHLC Mountain
Dynamic Chart
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores
Jan. 12
MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024
Jan. 12
CI
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024
Jan. 12
CI
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores
23-10-12
MT
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023
23-10-11
CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024
23-10-11
CI
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023
23-07-10
MT
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024
23-07-10
CI
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024
23-07-10
CI
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings
23-04-11
MT
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023
23-04-10
CI
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023
23-04-10
CI
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy
23-01-15
MT
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter of Fiscal 2023; Provides Dividend Guidance for the Full Year of Fiscal Year Ending May 31, 2023
23-01-13
CI
Cosmos Pharmaceutical Corporation Provides Earnings Forecast for the Fiscal Year Ending May 31, 2023
23-01-13
CI
More news
Criptomonedas: Tres temáticas a tener en cuenta
Dec. 21
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Demant, Lufthansa, AXA, BAE Systems, Adidas, GSK, Demant, Just Eat...
23-08-08
Revenez, la semaine n'est pas finie !
23-08-08
AVIS D'ANALYSTES DU JOUR : Saint-Gobain, AXA, Crédit Agricole, Adidas, Demant, Ipsen, Just Eat...
23-08-08
AVIS D'ANALYSTES DU JOUR : Airbus, Thales, STMicroelectronics, FDJ, Ubisoft, TF1, Ferrari, Cosmo...
23-01-31
More news 1 day +0.24%
1 week +0.56%
Current month -2.02%
1 month -2.35%
3 months -13.02%
6 months -8.67%
Current year -11.97%
More quotes
Managers
Title Age Since
President
43
03-03-31
Director of Finance/CFO
58
94-03-31
Chief Tech/Sci/R&D Officer
-
-
Members of the board
Title Age Since
Director/Board Member
50
05-03-31
Director/Board Member
52
98-10-31
Director of Finance/CFO
58
94-03-31
More insiders
Date
Price
Change
Volume
24-03-28
14,335
+0.24%
120 500
24-03-27
14,300
-0.73%
148,300
24-03-26
14,405
+1.02%
146,000
24-03-25
14,260
+0.35%
145,100
24-03-22
14,210
-0.63%
150,700
Delayed Quote
Japan Exchange, March 28, 2024 at 02:00 am EDT
More quotes
COSMOS Pharmaceutical Corporation is a company primarily engaged in the operation of drug stores. The Company offers medical goods, including general self-medication products, tonic drinks, oral care products, nursing care products, vitamin supplements, health food products, diet food and dispensing. Cosmetic products include cosmetic products for women and men, hair care products and bath agents. Miscellaneous goods include baby goods, detergents, insecticides, deodorizers, bath goods, toiletries, cookware, gardening goods, automobile goods and clothing products. General food products include processed food products, daily food products, seasonings, confectionery, non-alcoholic beverages and alcoholic beverages. It also provides tobacco and others.
More about the company
Last Close Price
14,335
JPY
Average target price
16,585
JPY
Spread / Average Target
+15.69%
Consensus
1st Jan change
Capi.
-11.97% 3.74B -16.48% 3.5B +19.50% 3.1B -1.24% 2.3B -2.78% 1.98B +7.34% 1.38B -14.45% 1.05B -34.26% 739M 0.00% 470M -0.60% 394M
Retail - Drugs with Grocery
Stock Equities
Stock COSMOS Pharmaceutical Corporation - Japan Exchange
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1